Nicht nur Globuli: Krankenkassen übernehmen teils ungewöhnliche Leistungen – von Baby-Yoga über Fitnesstracker bis Heileurythmie.

The federal government’s reclassification of medical marijuana products as Schedule III drugs doesn’t federally legalize marijuana, but it might extend tax breaks to some cannabis businesses.

When the U.S. Department of Justice moved to reclassify medical marijuana to a Schedule III drug on April 23, 2026, it set the stage for a vast amount of medical research that has been hobbled for ...

When you’re looking for a trusted cannabis dispensary in Connecticut, look no further than this list, which features top-rated dispensaries offering everything from recreational cannabis to edibles, ...

On April 23, acting U.S. attorney general Todd Blanche signed an order changing the federal classification of medical marijuana. The move, which came at the behest of President Donald Trump and will ...

Smoking cannabis leads to lung damage, but in a different way to tobacco, new research has found. The findings come from the long-running Dunedin Multidisciplinary Health and Development Study, which ...

Medical marijuana could finally be inching toward federal approval. After decades of advocacy from cannabis proponents and the marijuana industry, the Trump administration is moving to ease some ...

Research investigating cannabis and sleep is limited. However, products with a small-to-moderate amount of tetrahydrocannabinol (THC) and a small amount of cannabidiol (CBD) could be helpful. You may ...

Investing in marijuana ETFs (exchange-traded funds), which are funds that own stakes in multiple cannabis companies, is one way to potentially profit from the cannabis industry's growth. For some ...

Cannabis (Cannabis sativa) is an herbal drug. It contains chemicals called cannabinoids, including delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). The cannabinoids in cannabis work by ...

Kriminelle Hacker haben in Hannover einen Verein angegriffen, der Kassenrezepte prüft. Anfang Mai seien Hinweise auf einen ...

Merz konnte den Patentstreit bei Fampyra (Fampridin) für sich entscheiden und den Patentschutz bis 25. Juli sichern. Eine ...